ENST00000784515.1:n.209+1867_209+1868insACACACACACACAC

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

The ENST00000784515.1(ENSG00000302122):​n.209+1867_209+1868insACACACACACACAC variant causes a intron change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 975 hom., cov: 0)

Consequence

ENSG00000302122
ENST00000784515.1 intron

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.32

Publications

9 publications found
Variant links:
Genes affected
GRIN2A (HGNC:4585): (glutamate ionotropic receptor NMDA type subunit 2A) This gene encodes a member of the glutamate-gated ion channel protein family. The encoded protein is an N-methyl-D-aspartate (NMDA) receptor subunit. NMDA receptors are both ligand-gated and voltage-dependent, and are involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. These receptors are permeable to calcium ions, and activation results in a calcium influx into post-synaptic cells, which results in the activation of several signaling cascades. Disruption of this gene is associated with focal epilepsy and speech disorder with or without cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
GRIN2A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Landau-Kleffner syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • continuous spikes and waves during sleep
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • rolandic epilepsy-speech dyspraxia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • self-limited epilepsy with centrotemporal spikes
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.15 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000302122ENST00000784515.1 linkn.209+1867_209+1868insACACACACACACAC intron_variant Intron 1 of 2
ENSG00000302122ENST00000784516.1 linkn.209+1867_209+1868insACACACACACACAC intron_variant Intron 1 of 1
ENSG00000302122ENST00000784517.1 linkn.208+1867_208+1868insACACACACACACAC intron_variant Intron 1 of 2
GRIN2AENST00000675398.2 linkc.-1124_-1123insGTGTGTGTGTGTGT upstream_gene_variant ENSP00000502752.1 A0A6Q8PHM7

Frequencies

GnomAD3 genomes
AF:
0.103
AC:
12886
AN:
125226
Hom.:
976
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0522
Gnomad AMI
AF:
0.184
Gnomad AMR
AF:
0.0915
Gnomad ASJ
AF:
0.132
Gnomad EAS
AF:
0.110
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.112
Gnomad MID
AF:
0.145
Gnomad NFE
AF:
0.125
Gnomad OTH
AF:
0.103
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.103
AC:
12881
AN:
125290
Hom.:
975
Cov.:
0
AF XY:
0.104
AC XY:
6146
AN XY:
59330
show subpopulations
African (AFR)
AF:
0.0522
AC:
1692
AN:
32434
American (AMR)
AF:
0.0915
AC:
1166
AN:
12750
Ashkenazi Jewish (ASJ)
AF:
0.132
AC:
419
AN:
3182
East Asian (EAS)
AF:
0.110
AC:
445
AN:
4042
South Asian (SAS)
AF:
0.161
AC:
529
AN:
3280
European-Finnish (FIN)
AF:
0.112
AC:
782
AN:
6966
Middle Eastern (MID)
AF:
0.144
AC:
34
AN:
236
European-Non Finnish (NFE)
AF:
0.125
AC:
7493
AN:
59912
Other (OTH)
AF:
0.103
AC:
174
AN:
1688
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
470
941
1411
1882
2352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0895
Hom.:
154

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3219790; hg19: chr16-10277424; API